Tandem Diabetes Care (TNDM) Raw Materials (2014 - 2019)

Tandem Diabetes Care's Raw Materials history runs 6 years deep, the most recent figure standing at $9.6 million for Q1 2019.

• Quarterly Raw Materials fell 7.79% year-over-year to $9.6 million in Q1 2019, while the trailing twelve-month figure through Mar 2019 was $9.6 million (down 7.79% YoY) and the FY2018 annual result came in at $6.6 million, down 35.88% from the prior year.
• Raw Materials was $9.6 million for Q1 2019 at Tandem Diabetes Care, up from $6.6 million in the prior quarter.
• Across five years, Raw Materials topped out at $12.1 million in Q2 2016 and bottomed at $6.6 million in Q4 2018.
• A 5-year average of $9.9 million and a median of $10.0 million in 2016 frame the typical range for Raw Materials.
• Annual changes were most pronounced in 2015 — Raw Materials jumped 49.7% — and 2018, when it tumbled 35.88%.
• Tandem Diabetes Care's Raw Materials stood at $10.6 million in 2015, then declined by 11.61% to $9.4 million in 2016, then grew by 10.17% to $10.3 million in 2017, then tumbled by 35.88% to $6.6 million in 2018, then jumped by 44.74% to $9.6 million in 2019.
• Business Quant data shows TNDM's Raw Materials at $9.6 million in Q1 2019, $6.6 million in Q4 2018, and $8.6 million in Q3 2018.